NCT04482023 Emotional Support and Stress Management in Patients Diagnosed With COVID-19 Status UNKNOWN Phase N/A
NCT04481633 Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection Status COMPLETED Phase NA
NCT04481620 Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT Status COMPLETED Phase N/A
NCT04480632 Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis Status UNKNOWN Phase PHASE2
NCT04480424 Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) Status COMPLETED Phase PHASE2
NCT04479644 Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198 Status COMPLETED Phase PHASE1
NCT04479631 Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196 Status COMPLETED Phase PHASE1
NCT04479358 Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 Status TERMINATED Phase PHASE2
NCT04479202 The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 Status COMPLETED Phase PHASE4
NCT04479137 Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul Status COMPLETED Phase N/A
NCT04478019 SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding Status COMPLETED Phase EARLY_PHASE1
NCT04477642 Abatacept for Patients With COVID-19 and Respiratory Distress Status WITHDRAWN Phase PHASE1/PHASE2
NCT04475991 Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults Status TERMINATED Phase PHASE2
NCT04475471 WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey Status UNKNOWN Phase N/A
NCT04475107 The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients Status COMPLETED Phase PHASE2